Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended		152 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
NET REVENUES
Sales			$ 3,740	$ 900	$ 457,866
Royalties		3,690	10,000	5,580	645,180
TOTAL NET REVENUE		3,690	13,740	6,480	1,103,046
COST OF SALES			2,036	373	426,984
GROSS PROFIT		3,690	11,704	6,107	676,062
OPERATING EXPENSES
Research and development	2,123	5,050	3,380	5,050	865,752
Patent costs					65,000
Legal and Accounting	79,462	34,630	169,809	44,599	1,431,821
Sales and Marketing	51,954	103,000	100,262	154,778	5,531,231
General and administrative	35,297	91,381	70,987	131,162	3,807,542
Total operating expenses	168,836	234,061	344,438	335,589	11,701,346
LOSS BEFORE OTHER INCOME	(168,836)	(230,371)	(332,734)	(329,482)	(11,025,284)
OTHER INCOME (EXPENSE)
Interest income	1	7	1	58	63,664
Interest expense	(80,251)	(84,295)	(151,958)	(168,468)	(2,065,019)
Gain on debt forgiveness		184,242		184,242	184,242
Gain on disposition of assets					4,722
Total Other Income (Expense)	(80,250)	99,954	(151,957)	15,832	(1,812,391)
LOSS BEFORE INCOME TAX BENEFIT	(249,086)	(130,417)	(484,691)	(313,650)	(12,837,675)
INCOME TAX BENEFIT					(165,000)
NET LOSS	$ (249,086)	$ (130,417)	$ (484,691)	$ (313,650)	$ (12,672,675)
BASIC AND DILUTED NET LOSS PER COMMON SHARE	$ 0.00	$ 0.00	$ 0.00	$ 0.00
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	145,144,603	138,343,237	145,144,603	147,008,538